Skip to main content
letter
. 2005 Jul;54(7):1047. doi: 10.1136/gut.2005.065789

Figure 1.

Figure 1

 Cumulative survival rate according to changes in the v signal score after two cycles of treatment. Median survival time (MST) of patients in the non-increased v signal group (n = 22) was 382 days (range 71–484) and for those in the increased group (n = 9), 176 days (range 68–257). MST in the increased group was significantly shorter compared with the non-increased group (log rank test; p = 0.0094).